Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -0.68% | -10.16% | -43.14% |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
May. 01 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
Financials (USD)
Sales 2024 * | 82.92M | Sales 2025 * | 98.71M | Capitalization | 281M |
---|---|---|---|---|---|
Net income 2024 * | -65M | Net income 2025 * | -61M | EV / Sales 2024 * | 3.39 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.85 x |
P/E ratio 2024 * |
-4.33
x | P/E ratio 2025 * |
-4.64
x | Employees | 279 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.01% |
Latest transcript on Pulmonx Corporation
1 day | -0.68% | ||
1 week | -10.16% | ||
1 month | -4.73% | ||
3 months | -21.37% | ||
6 months | -33.49% | ||
Current year | -43.14% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Olivera
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 07-12-31 | |
Lauren Cristina
ADM | Chief Administrative Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Ferrari
BRD | Director/Board Member | 70 | 07-01-31 |
Glendon French
BRD | Director/Board Member | 62 | 14-12-17 |
Dana Mead
CHM | Chairman | 64 | 10-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - | |
0.00% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7.25 | -0.68% | 1,137,108 |
24-05-30 | 7.3 | -3.05% | 332,281 |
24-05-29 | 7.53 | -5.99% | 987,558 |
24-05-28 | 8.01 | -0.74% | 185,529 |
24-05-24 | 8.07 | -3.70% | 272,255 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.14% | 281M | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+6.22% | 6.61B | |
+12.58% | 5.39B | |
-16.63% | 4.84B | |
+26.90% | 4.53B | |
-21.14% | 3.91B | |
-22.99% | 2.91B | |
+47.42% | 2.37B |
- Stock Market
- Equities
- LUNG Stock